Yunnan Botanee Bio-Technology GroupLTD Past Earnings Performance
Past criteria checks 2/6
Yunnan Botanee Bio-Technology GroupLTD has been growing earnings at an average annual rate of 16.3%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 21.3% per year. Yunnan Botanee Bio-Technology GroupLTD's return on equity is 12.7%, and it has net margins of 13.5%.
Key information
16.3%
Earnings growth rate
12.7%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | 21.3% |
| Return on equity | 12.7% |
| Net Margin | 13.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Yunnan Botanee Bio-Technology GroupLTD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 5,756 | 775 | 3,145 | 298 |
| 31 Dec 23 | 5,522 | 757 | 3,036 | 299 |
| 30 Sep 23 | 5,550 | 1,113 | 2,712 | 310 |
| 30 Jun 23 | 5,332 | 1,106 | 2,590 | 282 |
| 31 Mar 23 | 5,069 | 1,064 | 2,424 | 258 |
| 01 Jan 23 | 5,014 | 1,051 | 2,390 | 255 |
| 30 Sep 22 | 4,805 | 1,025 | 2,353 | 171 |
| 30 Jun 22 | 4,660 | 993 | 2,270 | 152 |
| 31 Mar 22 | 4,323 | 930 | 2,107 | 121 |
| 01 Jan 22 | 4,022 | 863 | 1,932 | 113 |
| 30 Sep 21 | 3,332 | 683 | 1,622 | 85 |
| 30 Jun 21 | 3,107 | 648 | 1,450 | 82 |
| 31 Mar 21 | 2,825 | 568 | 1,378 | 72 |
| 31 Dec 20 | 2,636 | 544 | 1,281 | 63 |
| 31 Dec 19 | 1,944 | 412 | 984 | 51 |
| 31 Dec 18 | 1,240 | 261 | 632 | 43 |
| 31 Dec 17 | 798 | 154 | 415 | 28 |
Quality Earnings: 300957 has high quality earnings.
Growing Profit Margin: 300957's current net profit margins (13.5%) are lower than last year (21%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300957's earnings have grown by 16.3% per year over the past 5 years.
Accelerating Growth: 300957's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300957 had negative earnings growth (-27.1%) over the past year, making it difficult to compare to the Personal Products industry average (-0.2%).
Return on Equity
High ROE: 300957's Return on Equity (12.7%) is considered low.